Tus Pharmaceutical Group Co Ltd (000590) — Net Asset Momentum
Tus Pharmaceutical Group Co Ltd (000590) recorded a net asset momentum of -8.6% as of December 2025, with net assets of CN¥549.49 Million CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 000590 total equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Tus Pharmaceutical Group Co Ltd Net Asset Momentum (1995–2025)
This chart tracks Tus Pharmaceutical Group Co Ltd's year-over-year net asset growth across 31 annual reporting periods from 1995 to 2025. The most recent momentum reading is -8.6%, with net assets of CN¥549.49 Million CNY as of December 2025. For live market cap and overall valuation, see 000590 market cap.
Annual Net Asset History for Tus Pharmaceutical Group Co Ltd (1995–2025)
The table below shows the complete annual net asset history for Tus Pharmaceutical Group Co Ltd from 1995 to 2025, covering 31 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check 000590 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥549.49 Million | CN¥889.47 Million | CN¥339.98 Million | ▼ -8.6% |
| 2024 | CN¥601.23 Million | CN¥1.01 Billion | CN¥412.18 Million | ▼ -17.4% |
| 2023 | CN¥728.20 Million | CN¥1.15 Billion | CN¥422.92 Million | ▲ +3.7% |
| 2022 | CN¥702.49 Million | CN¥1.17 Billion | CN¥464.26 Million | ▲ +3.0% |
| 2021 | CN¥682.32 Million | CN¥967.83 Million | CN¥285.50 Million | ▲ +5.8% |
| 2020 | CN¥644.88 Million | CN¥892.16 Million | CN¥247.27 Million | ▲ +3.7% |
| 2019 | CN¥622.16 Million | CN¥846.74 Million | CN¥224.58 Million | ▲ +7.3% |
| 2018 | CN¥579.72 Million | CN¥816.60 Million | CN¥236.88 Million | ▼ -0.6% |
| 2017 | CN¥583.33 Million | CN¥873.74 Million | CN¥290.40 Million | ▲ +121.0% |
| 2016 | CN¥263.96 Million | CN¥630.68 Million | CN¥366.72 Million | ▲ +28.3% |
| 2015 | CN¥205.79 Million | CN¥587.43 Million | CN¥381.64 Million | ▲ +11.8% |
| 2014 | CN¥184.11 Million | CN¥586.82 Million | CN¥402.71 Million | ▼ -31.7% |
| 2013 | CN¥269.51 Million | CN¥552.56 Million | CN¥283.05 Million | ▼ -43.7% |
| 2012 | CN¥478.58 Million | CN¥704.02 Million | CN¥225.44 Million | ▲ +36.4% |
| 2011 | CN¥350.83 Million | CN¥602.45 Million | CN¥251.62 Million | ▲ +25.8% |
| 2010 | CN¥278.88 Million | CN¥568.73 Million | CN¥289.85 Million | ▲ +20.6% |
| 2009 | CN¥231.22 Million | CN¥516.33 Million | CN¥285.11 Million | ▼ -28.4% |
| 2008 | CN¥322.78 Million | CN¥571.31 Million | CN¥248.53 Million | ▲ +5.1% |
| 2007 | CN¥307.22 Million | CN¥548.58 Million | CN¥241.37 Million | ▲ +13.3% |
| 2006 | CN¥271.26 Million | CN¥545.36 Million | CN¥274.10 Million | ▲ +1.0% |
| 2005 | CN¥268.54 Million | CN¥664.58 Million | CN¥396.04 Million | ▲ +0.4% |
| 2004 | CN¥267.57 Million | CN¥676.63 Million | CN¥409.06 Million | ▲ +3.2% |
| 2003 | CN¥259.16 Million | CN¥685.16 Million | CN¥426.00 Million | ▼ -7.7% |
| 2002 | CN¥280.91 Million | CN¥724.86 Million | CN¥443.96 Million | ▲ +0.8% |
| 2001 | CN¥278.65 Million | CN¥695.05 Million | CN¥416.40 Million | ▼ -26.7% |
| 2000 | CN¥380.02 Million | CN¥636.26 Million | CN¥256.24 Million | ▲ +9.3% |
| 1999 | CN¥347.80 Million | CN¥596.86 Million | CN¥249.06 Million | ▲ +29.4% |
| 1998 | CN¥268.78 Million | CN¥404.35 Million | CN¥135.56 Million | ▲ +11.6% |
| 1997 | CN¥240.92 Million | CN¥373.15 Million | CN¥132.23 Million | ▲ +69.8% |
| 1996 | CN¥141.91 Million | CN¥187.46 Million | CN¥45.54 Million | ▲ +117.3% |
| 1995 | CN¥65.32 Million | CN¥141.06 Million | CN¥75.74 Million | — |